nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—Atrioventricular block second degree—Hydrochlorothiazide—nephrolithiasis	0.0728	0.078	CcSEcCtD
Dolasetron—Arrhythmia supraventricular—Hydrochlorothiazide—nephrolithiasis	0.0536	0.0575	CcSEcCtD
Dolasetron—Hyoscyamine—CHRM3—nephrolithiasis	0.0363	0.541	CrCbGaD
Dolasetron—Atropine—CHRM3—nephrolithiasis	0.0308	0.46	CrCbGaD
Dolasetron—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0281	0.0301	CcSEcCtD
Dolasetron—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0272	0.0291	CcSEcCtD
Dolasetron—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0253	0.0271	CcSEcCtD
Dolasetron—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0208	0.0223	CcSEcCtD
Dolasetron—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0195	0.0209	CcSEcCtD
Dolasetron—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.0188	0.0202	CcSEcCtD
Dolasetron—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.0174	0.0187	CcSEcCtD
Dolasetron—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.0172	0.0184	CcSEcCtD
Dolasetron—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.0169	0.0181	CcSEcCtD
Dolasetron—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0161	0.0172	CcSEcCtD
Dolasetron—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0157	0.0168	CcSEcCtD
Dolasetron—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.0146	0.0156	CcSEcCtD
Dolasetron—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0142	0.0152	CcSEcCtD
Dolasetron—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0148	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0146	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0133	0.0143	CcSEcCtD
Dolasetron—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0141	CcSEcCtD
Dolasetron—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0137	CcSEcCtD
Dolasetron—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0131	CcSEcCtD
Dolasetron—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0125	CcSEcCtD
Dolasetron—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0123	CcSEcCtD
Dolasetron—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0122	CcSEcCtD
Dolasetron—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0122	CcSEcCtD
Dolasetron—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0119	CcSEcCtD
Dolasetron—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.011	0.0118	CcSEcCtD
Dolasetron—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0114	CcSEcCtD
Dolasetron—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.0103	0.011	CcSEcCtD
Dolasetron—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0108	CcSEcCtD
Dolasetron—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00974	0.0104	CcSEcCtD
Dolasetron—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00969	0.0104	CcSEcCtD
Dolasetron—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00933	0.01	CcSEcCtD
Dolasetron—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00896	0.0096	CcSEcCtD
Dolasetron—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.0089	0.00954	CcSEcCtD
Dolasetron—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00852	0.00913	CcSEcCtD
Dolasetron—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00844	0.00904	CcSEcCtD
Dolasetron—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.0084	0.00901	CcSEcCtD
Dolasetron—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00836	0.00896	CcSEcCtD
Dolasetron—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00831	0.00891	CcSEcCtD
Dolasetron—Malaise—Hydrochlorothiazide—nephrolithiasis	0.0082	0.00879	CcSEcCtD
Dolasetron—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00817	0.00876	CcSEcCtD
Dolasetron—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00815	0.00874	CcSEcCtD
Dolasetron—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00804	0.00861	CcSEcCtD
Dolasetron—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00799	0.00857	CcSEcCtD
Dolasetron—Cough—Hydrochlorothiazide—nephrolithiasis	0.00793	0.00851	CcSEcCtD
Dolasetron—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00774	0.0083	CcSEcCtD
Dolasetron—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00774	0.0083	CcSEcCtD
Dolasetron—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00774	0.0083	CcSEcCtD
Dolasetron—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00771	0.00827	CcSEcCtD
Dolasetron—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00765	0.0082	CcSEcCtD
Dolasetron—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00757	0.00812	CcSEcCtD
Dolasetron—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00748	0.00802	CcSEcCtD
Dolasetron—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00742	0.00795	CcSEcCtD
Dolasetron—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00742	0.00795	CcSEcCtD
Dolasetron—Shock—Hydrochlorothiazide—nephrolithiasis	0.0073	0.00783	CcSEcCtD
Dolasetron—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00727	0.00779	CcSEcCtD
Dolasetron—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00724	0.00776	CcSEcCtD
Dolasetron—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00717	0.00769	CcSEcCtD
Dolasetron—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00707	0.00758	CcSEcCtD
Dolasetron—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00693	0.00743	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00676	0.00725	CcSEcCtD
Dolasetron—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00666	0.00714	CcSEcCtD
Dolasetron—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00662	0.00709	CcSEcCtD
Dolasetron—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.0066	0.00707	CcSEcCtD
Dolasetron—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00653	0.007	CcSEcCtD
Dolasetron—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00645	0.00691	CcSEcCtD
Dolasetron—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.0064	0.00686	CcSEcCtD
Dolasetron—Pain—Hydrochlorothiazide—nephrolithiasis	0.00635	0.0068	CcSEcCtD
Dolasetron—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00635	0.0068	CcSEcCtD
Dolasetron—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00612	0.00656	CcSEcCtD
Dolasetron—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00607	0.0065	CcSEcCtD
Dolasetron—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.0059	0.00632	CcSEcCtD
Dolasetron—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00587	0.00629	CcSEcCtD
Dolasetron—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00587	0.00629	CcSEcCtD
Dolasetron—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00547	0.00586	CcSEcCtD
Dolasetron—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00532	0.00571	CcSEcCtD
Dolasetron—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00525	0.00563	CcSEcCtD
Dolasetron—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00508	0.00544	CcSEcCtD
Dolasetron—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00491	0.00526	CcSEcCtD
Dolasetron—Rash—Hydrochlorothiazide—nephrolithiasis	0.00468	0.00502	CcSEcCtD
Dolasetron—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00467	0.00501	CcSEcCtD
Dolasetron—Headache—Hydrochlorothiazide—nephrolithiasis	0.00465	0.00498	CcSEcCtD
